Medicare Enrolled

Tracy Garrett-Reed, DNP, APRN, FNP-C

Nurse Practitioner - Family · Baytown, TX
4021 GARTH RD STE 101, Baytown, TX 77521
2814207211
Registered in NPPES since 2012
NPI: 1760744783 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Garrett-Reed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Garrett-Reed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Garrett-Reed

Tracy Garrett-Reed is a nurse practitioner - family in Baytown, TX, with 14 years of NPI registration.

Between the years covered by Open Payments, Garrett-Reed received a total of $8,145 from 43 pharmaceutical and/or device companies across 141 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Garrett-Reed is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration $8,145 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,145
Total received (2021-2024)
Avg $2,036/year across 4 years
Top 2% in TX for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
141
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,892
2023
$2,014
2022
$3,016
2021
$1,223

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$501
Daiichi Sankyo Inc.
$278
Incyte Corporation
$215
Takeda Pharmaceuticals U.S.A., Inc.
$125
Pharmacosmos Therapeutics Inc.
$122
GlaxoSmithKline, LLC.
$115
Exelixis Inc.
$110
Ipsen Biopharmaceuticals, Inc
$107
Tempus AI, Inc
$100
Myriad Genetic Laboratories, Inc.
$80
Merck Sharp & Dohme LLC
$73
Novartis Pharmaceuticals Corporation
$41
Gilead Sciences, Inc.
$25
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$1,417
Daiichi Sankyo Inc.
$621
Incyte Corporation
$500
Merck Sharp & Dohme LLC
$470
Seagen Inc.
$437
E.R. Squibb & Sons, L.L.C.
$327
Takeda Pharmaceuticals U.S.A., Inc.
$279
Genentech USA, Inc.
$265
Gilead Sciences, Inc.
$246
Kite Pharma, Inc.
$238
Amgen Inc.
$227
Medical Device Business Services, Inc.
$227
Janssen Biotech, Inc.
$185
Novartis Pharmaceuticals Corporation
$184
Myriad Genetic Laboratories, Inc.
$180
SANOFI-AVENTIS U.S. LLC
$178
Regeneron Healthcare Solutions, Inc.
$139
Astellas Pharma US Inc
$130
Ipsen Biopharmaceuticals, Inc
$129
ADC Therapeutics America, Inc.
$129
GlaxoSmithKline, LLC.
$128
ABBVIE INC.
$125
Coherus Biosciences Inc.
$124
Pharmacosmos Therapeutics Inc.
$122
Alkermes, Inc.
$120
PUMA BIOTECHNOLOGY, INC.
$113
Lilly USA, LLC
$111
Exelixis Inc.
$110
Tempus AI, Inc
$100
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$100
Blueprint Medicines Corporation
$85
Apellis Pharmaceuticals, Inc.
$81
Bayer HealthCare Pharmaceuticals Inc.
$59
Merck Sharp & Dohme Corporation
$55
Pharmacyclics LLC, an AbbVie Company
$41
GENZYME CORPORATION
$38
EISAI INC.
$30
BeiGene USA, Inc.
$18
Sobi, Inc
$17
PFIZER INC.
$17
EMD Serono, Inc.
$17
Celgene Corporation
$15
Stemline Therapeutics Inc.
$12
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CYRAMZA · DARZALEX · DOPTELET · ELZONRIS · ENHERTU · ERLEADA · Enhertu · Epclusa · GAVRETO · HUMIRA · Halaven · Herceptin · ICLUSIG · IMBRUVICA · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · LifeVest · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nubeqa · OJJAARA · OPDIVO · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · REBLOZYL · SOMATULINE DEPOT · TAGRISSO · TECENTRIQ · Udenyca · VENCLEXTA · VIVITROL · Xtandi · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Baytown?
Compare family nurse practitioners in the Baytown area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
911
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Garrett-Reed is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Garrett-Reed receive payments from pharmaceutical companies?
Yes. Garrett-Reed received a total of $8,145 from 43 companies across 141 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Garrett-Reed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →